Robert Ozols of the Fox Chase Cancer Center in Philadelphia joins Derek Thorne to talk about the top presentations on cancer prevention.
– Raloxifene is as good as tamoxifen at preventing breast cancer in high-risk women. Lawrence Wickerham of the National Surgical Adjuvant Breast and Bowel Project in Pittsburgh presented the clinical data from the STAR trial, while Patricia Ganz of UCLA had information on quality of life (Abstracts 5 and 561)
– The human papillomavirus vaccine (HPV) doesn’t just protect against cervical cancer – it may protect against vaginal and vulvar cancers as well. That’s according to findings from the FUTURE II study, presented by Jorma Paavonen of the University of Helsinki (Abstract 5011)
– Noah Kauff, of the Memorial Sloan-Kettering Cancer Center in New York, has data confirming that women with mutations in the genes for BRCA1 and 2 can reduce their risk of breast and ovarian cancer if they have their ovaries and fallopian tubes removed (Abstract 1003)